绿茶婊

北京时间7月20日凌晨，万众瞩目的2026年美加墨世界杯决赛在西班牙队与阿根廷队之间打响。结果，占据绝对优势的西班牙队凭借加时赛费兰·托雷斯的爆射破门，1比0击败阿根廷队，2010年后再夺世界杯冠军！执法决赛的主裁判是来自斯洛文尼亚的温契奇，这位46岁的裁判此前执法了巴西队1比1摩洛哥队、阿尔及利亚队2比1约旦队的小组赛，以及墨西哥队2比0厄瓜多尔队的1/16决赛。    (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed.    China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval.    A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country.    Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category.    This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading.     At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly.    To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong.    The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions.    In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total.        (By Tang Yuxian)                    。

二 | 值得一提的是，2022年世界杯阿根廷队1比2爆冷不敌沙特队的比赛，就是温契奇执法的。今日温契奇的执法尺度相对较为宽松，这也在上半场引发广泛争议，多名国外媒体人都质疑阿根廷队中场麦卡利斯特多次犯规却没有吃到黄牌。

三 | 担任评论员的英格兰足球名宿理查兹就表示：“麦卡利斯特本应吃到一张黄牌，（裁判没有出牌）开了一个危险的先例，阿根廷队会觉得他们可以肆无忌惮地粗暴对待西班牙！”▲阿根廷队球员麦卡利斯特对奥尔莫犯规 图据IC photo《每日体育报》主持人冈萨雷斯也直言，从具体判罚来看，主裁判是“偏袒”阿根廷队的。

四 | 但阿根廷队明显也会对温契奇不满，因为在90分钟常规时间补时阶段，温契奇向恩佐出示第二张黄牌，将其罚下，也让阿根廷队在加时赛中少打一人，这决定了最终的结果，当时多名阿根廷球员围住温契奇进行理论。

五 | 而在加时赛上半场，西班牙队的尼科·威廉斯曾打进一球，但温契奇判罚梅里诺在禁区内犯规在先，因此进球无效。但从慢镜看，梅里诺无论对奥塔门迪还是门将马丁内斯，似乎都没有明显的犯规动作，但VAR也并未介入这次判罚，支持了温契奇的决定。赛后，这次判罚也引起了各方的议论。

六 | ▲温契奇出示红牌罚下阿根廷球员恩佐 图据IC photo总而言之，温契奇这场比赛的执法表现难言完美，但不管怎么说，担任世界杯决赛的主裁判让他名声大噪，而且其获得的收益也是极高。有媒体就用“世界杯决赛裁判收入令人难以置信”为标题，报道了温契奇在这场决赛以及本届世界杯上的收入情况。每四年一次的世界杯，让国际足联在电视转播权、门票收入、赞助收入等方面赚得盆满钵满。有消息称，2023年-2026年这个周期中，国际足联的总收入将达到130亿美元。财大气粗的国际足联也十分豪爽，各支参赛队都能获得不菲的出场费和奖金，而对执法本届世界杯的裁判员们，国际足联也十分慷慨。英国媒体报道称，每名被召集参加美加墨世界杯执法的裁判员都能获得10万美元（约合人民币67.76万元）的固定报酬，这个数字明显超出往届世界杯赛事。另外，裁判员们每参加一场比赛的执法工作，还能获得额外的酬劳，比如小组赛期间主裁判每场比赛的报酬在3000美元-5000美元之间，淘汰赛阶段每场比赛可获得高达10000美元（约合人民币6.77万元）的报酬。媒体统计了温契奇在本届世界杯的报酬情况，他在决赛中的执法会得到10000美元的酬劳。再加上本届赛事的固定报酬、小组赛报酬、淘汰赛报酬，其在本届世界杯上的总收入折合人民币将达到80.62万元！这次美加墨执法之旅结束时，温契奇能带着超过约80万回家，也难怪有媒体会直呼“难以置信”！据悉，决赛中参与执法的助理裁判及VAR裁判也能获得相应报酬，但相对主裁判数额较低，每人可获得约5000美元。

七 | 红星新闻记者 姜山